Dapsone 100 mg
NDC 83098-101, Dapsone Tablets, tablet, from Everest Life Sciences. LLC.
- Product NDC
- 83098-101
- Status
- Listed
- Labeler
- Everest Life Sciences. LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA086842
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83098-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPSONE100 mg/1
Pharmacologic classes
Sulfone [EPC]; Sulfones [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83098-101-01 | 83098010101 | 100 TABLET in 1 BOTTLE (83098-101-01) |
| 83098-101-03 | 83098010103 | 30 TABLET in 1 BOTTLE (83098-101-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1d026bb6-05da-e9cf-e063-6394a90a2485
Use it
Look up 83098-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83098-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83098-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.